Loading...
Docoh

NB Crossroads Private Markets Access Fund

Filed: 14 Mar 22, 1:42pm
 

 

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

 

SCHEDULE TO

 

TENDER OFFER STATEMENT UNDER SECTION 14(D)(1) OR 13(E)(1)
OF THE SECURITIES EXCHANGE ACT OF 1934

 

(FINAL AMENDMENT)

 

NB CROSSROADS PRIVATE MARKETS ACCESS FUND LLC

(Name of Subject Company (Issuer))

 

NB CROSSROADS PRIVATE MARKETS ACCESS FUND LLC

(Name of Filing Person(s) (Issuer))

 

INSTITUTIONAL CLASS SHARES OF LIMITED LIABILITY COMPANY INTERESTS
(Title of Class of Securities)

 

63946V106
(CUSIP Number of Class of Securities)

 

Corey Issing

Neuberger Berman Investment Advisers LLC

1290 Avenue of the Americas

New York, NY 10104
(212) 476-8800
(Name, address, and telephone numbers of person authorized to receive notices
and communications on behalf of filing persons)

 

With a copy to:
Nicole M. Runyan, Esq.

Proskauer Rose LLP

Eleven Times Square

New York, NY 10036

(212) 969-3000

 

¨Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.

 

Check the appropriate boxes below to designate any transactions to which the statement relates:

 

¨third-party tender offer subject to Rule 14d-1.

 

xissuer tender offer subject to Rule 13e-4.

 

¨going-private transaction subject to Rule 13e-3.

 

¨amendment to Schedule 13D under Rule 13d-2.

 

Check the following box if the filing is a final amendment reporting the results of the tender offer: x

 

 
 

 

 

Item 1 through Item 9 and Item 11.

 

This Final Amendment relates to the Issuer Tender Offer Statement on Schedule TO (the “Schedule TO”) originally filed on January 31, 2022 by NB Crossroads Private Markets Access Fund LLC (the “Fund”) in connection with an offer (the “Offer”) by the Fund to purchase up to $16,376,038 of shares of limited liability company interest of the Fund (“Shares”) upon the terms and subject to the conditions set forth in the Offer to Purchase and the related Letter of Transmittal. Copies of the Offer to Purchase and Letter of Transmittal were previously filed as Exhibits B and C to the Schedule TO.

 

This is the Final Amendment to the Schedule TO and is being filed to report the results of the Offer. Capitalized terms not otherwise defined herein shall have the meanings ascribed to them in the Offer to Purchase.

 

The following information is furnished pursuant to Rule 13e-4(c)(4) under the Securities Exchange Act of 1934, as amended:

 

1.       The Offer expired at 11:59 p.m., Eastern Time, on February 28, 2022.

 

2.       No Shares were tendered prior to the expiration of the Offer and no Shares were withdrawn prior to the expiration of the Offer. As no Shares were validly tendered, the Fund is not purchasing any Shares as a result of the Offer and is able to file the Final Amendment prior to the Valuation Date and Repurchase Date.

 

Item 12(b). Filing Fee

 

Filing Fee Exhibit

 

 

 

 

SIGNATURE

 

After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

 NB CROSSROADS PRIVATE MARKETS ACCESS FUND LLC 
    
    
 By:/s/ James D. Bowden 
 Name:James D. Bowden 
 Title:President and Chief Executive Officer 

 

March 14, 2022